C12Y 101/01159
7-alpha-hydroxysteroid dehydrogenase
Official title: 7-Alpha-hydroxysteroid dehydrogenase (1.1.1.159)
C12Y101/01159 (7-alpha-hydroxysteroid dehydrogenase) appears on 6 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 10
- Assignees
- 4
- Inventors
- 25
- Latest grant
- 16 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 1 | 2 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 2 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for reducing clostridium difficile infection16 Sep 2025US 12,414,969 B2Memorial Sloan Kettering Cancer Center
- Coupled, self-sufficient biotransformation of chenodeoxcholic acid to ursodeoxycholic acid and novel enzyme mutants applicable in said process25 Apr 2023US 11,634,743 B2PharmaZell GmbH
- Methods and compositions for reducing Clostridium difficile infection18 Oct 2022US 11,471,495 B2Memorial Sloan Kettering Cancer Center
- 3α-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid19 Apr 2022US 11,306,343 B2PharmaZell GmbH
- 3-alpha-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid26 Nov 2019US 10,487,348 B2PharmaZell GmbH
- Methods and compositions for reducing clostridium difficile infection23 Apr 2026US 2026/0108564 A1Memorial Sloan Kettering Cancer Center
- Compositions and methods for modifying bile acids to regulate lipid and steroid metabolism11 Dec 2025US 2025/0375505 A1The Regents of the University of California
- Methods and compositions for reducing clostridium difficile infection22 Jun 2023US 2023/0190825 A1Memorial Sloan Kettering Cancer Center
- Cells and Methods for the Production of Ursodeoxycholic Acid and Precursors Thereof4 Nov 2021US 2021/0340504 A1
- Coupled, Self-Sufficient Biotransformation of Chenodeoxcholic Acid to Ursodeoxycholic Acid and Novel Enzyme Mutants Applicable in said Process31 Dec 2020US 2020/0407766 A1PharmaZell GmbH
Most cited
By later US patents